Trial intelligence / Profile preview

Noradrenergic Influence on Intrusive Memories

NCT02541071Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Nov 2013
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Yohimbine, Clonidine and Placebo (3 arms). Primary endpoint: Number of intrusive memories at 4 days. Started Nov 2013; status: completed.

02

Drugs

yohimbineclonidine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT02541071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02541071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call